Use of N-phenyl-2-pyrimidineamine derivatives against mast cell-based diseases like allergic disorders

Details for Australian Patent Application No. 2006200436 (hide)

Owner Novartis AG Komiyama, A. Takeuchi, K. The Government of the United States Department of Veterans Affairs Oregon Health and Science University Koike, K.

Inventors koike, Kenichi; Takeuchi, Kovichi; Nakajima, Motowo; Komiyama, Atusushi; Heinrich, Michael

Agent Davies Collison Cave

Pub. Number AU-A-2006200436

Parent 2002307140

Filing date 1 February 2006

Wipo publication date 23 February 2006

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

Event Publications

16 February 2006 Complete Application Filed

23 February 2006 Application Open to Public Inspection

  Published as AU-A-2006200436

14 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006200437-Substituted alkylamine derivatives and methods of use

2006200435-Gaming machine, game control method and game system